CD8A and colorectal carcinoma: The data showed that MGPfact significantly improved the explanatory power for most CD8+ T cell subtypes over Monocle 2, which was used in the original studies (p<0.05, see Table 2 and Supplementary file 6), except for the CD8-GZMK cells in the CRC dataset.